Components of this manuscript were presented at the Americas Hepato-Pancreato-Biliary Association annual conference in Miami, Florida.
The authors declare that they have no competing interests.
All authors participated equally in the conceptualization, construction, editing and finalizing of this manuscript, as well as the consensus building process. All authors read and approved the final manuscipt.
Pancreaticoduodenectomy remains the exclusive technique for surgical resection of cancers located within both the pancreatic head and periampullary region. Amongst peri-procedural complications, hemorrhage is particularly problematic given that allogenic blood transfusions are known to increase the risk of infection, acute lung injury, cancer recurrence and overall 30-day morbidity and mortality rates. Because blood loss can be considered a modifiable factor that reflects surgical technique, rates of perioperative blood loss and transfusion have been advocated as robust quality indicators. We present a correspondence manuscript that outlines peri-procedural concepts detailing a successful pancreaticoduodenectomy with minimal hemorrhage. These tips were collated from master pancreatic surgeons throughout the globe who have performed over 10,000 cumulative pancreaticoduodenectomies. At risk scenarios for hemorrhage include dissections of the superior mesenteric – portal vein, gastroduodenal artery, and retroperitoneal soft tissue margin. General principles in limiting slow continuous hemorrhage that may accumulate into larger total case losses are also discussed. While many of the techniques and tips proposed by master pancreas surgeons are intuitive and straight forward, when taken as a collective they represent a significant contribution to improved outcomes associated with the pancreaticoduodenectomy over the past 100 years.
Kaush W. Das carcinoma der papilla und seine radikale entfernung. Beitrage zur Klinishen Chirugie. 1912;78:29–33.
Crile Jr G. The advantage of bypass operations over radical pancreaticoduodenectomy in the treatment of pancreatic carcinoma. Surg Gynecol Obstet. 1970;130:1049–53. PubMed
McAlister FA, Clark HD, Wells PS, Laupacis A. Perioperative allogenic blood transfusion does not cause adverse sequelae in patients with cancer: a meta-analysis of unconfounded studies. Br J Surg. 2001;85:171–8. CrossRef
Miki C, Hiro J, Ojima E, Inoue Y, Mohri Y, Kusunoki M. Perioperative allogenic blood transfusion, the related cytokine response and long-term survival after potentially curative resection of colorectal cancer. Clin Oncol (R Coll Radiol). 2006;18:60–6. CrossRef
Crowe JP, Gordon NH, Fry DE, Shuck JM, Hubay CA. Breast cancer survival and perioperative blood transfusion. Surgery. 1989;106:836–41. PubMed
Nielson HJ. Detrimental effects of perioperative blood transfusion. Br J Surg. 1995;82:582–7. CrossRef
Galandiuk S, Polk HC, Jagelman DG, Fazio VW. Re-emphasis of priorities in surgical antibiotic prophylaxis. Surg Gyencol Obstet. 1989;169:219–22.
Proctor LD, Davenport DL, Bernard AC, Zwischenberger JB. General surgical operative duration is associated with increased risk-adjusted infectious complication rates and length of hospital stay. J Am Coll Surg. 2010;210:60–5. CrossRef
Ball CG, Kirkpatrick AW, Smith M. Traumatic injury to the superior mesenteric vein: ligate, repair or shunt? Eur J Trauma and Emerg Surg. 2007;3:550–2. CrossRef
- The view from 10,000 procedures: technical tips and wisdom from master pancreatic surgeons to avoid hemorrhage during pancreaticoduodenectomy
Chad G. Ball
Charles M. Vollmer
Thomas J. Howard
- BioMed Central
Neu im Fachgebiet Chirurgie
Mail Icon II